PF-Atlas › Clinical Trials › NCT02288429

Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium

colistimethate sodium · Not specified

Registry ID
NCT02288429
Phase
Not specified
Status
Completed
Drug / intervention
colistimethate sodium
Sponsor
University of Colorado, Denver
Start
2013-09
Enrollment
16
Locations
1

About this trial

Colistin is a polymixin antibiotic used in the treatment of multidrug-resistant gram-negative infections. Given the limited use of colistin and previous challenges with laboratory assays to determine plasma concentrations, there is a lack of knowledge of the pharmacokinetic profile of colistin. The purpose of the investigators observational prospective pharmacokinetic cohort study is to examine the steady-state pharmacokinetic and pharmacodynamic properties of intravenous colistimethate sodium in cystic fibrosis and critically ill patients.

View NCT02288429 on ClinicalTrials.gov →

Explore related

All colistimethate sodium trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT02288429 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.